Advanced Therapeutic Strategies and Resistance Mechanisms in CLL

Dr Paneesha discusses the evolving treatment landscape for relapsed CLL, focusing on BTK resistance, new options including cellular therapy, and the importance of patient-specific factors in treatment decisions.

Target Audience

Healthcare Professionals

This activity is supported by an educational grant from Eli Lilly.

Course summary

Available credit: 
  • 0.25 AMA PRA Category 1 Credit(s)™
Course opens: 
05/22/2025
Course expires: 
05/21/2028
Cost:
$0.00
Rating: 
0
Dr. Shankara Paneesha, MD FRCP FRCPath

Dr. Shankara Paneesha, MD FRCP FRCPath

Consultant Haematologist
Honorary Associate Clinical Professor, University of Birmingham
University Hospitals Birmingham NHS Foundation

Dr. Shankara Paneesha, MD FRCP FRCPath discloses the following: There is nothing to disclose

Available Credit

  • 0.25 AMA PRA Category 1 Credit(s)™

Price

Cost:
$0.00
Please login or register to take this course.